133 related articles for article (PubMed ID: 36088813)
21. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
22. Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
Mondello P; Steiner N; Willenbacher W; Ferrero S; Ghione P; Marabese A; Pitini V; Cuzzocrea S; Mian M
Oncologist; 2016 Sep; 21(9):1107-12. PubMed ID: 27382029
[TBL] [Abstract][Full Text] [Related]
23. Ensemble Feature Learning to Identify Risk Factors for Predicting Secondary Cancer.
Ye X; Li H; Sakurai T; Shueng PW
Int J Med Sci; 2019; 16(7):949-959. PubMed ID: 31341408
[No Abstract] [Full Text] [Related]
24. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
[TBL] [Abstract][Full Text] [Related]
25. Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer.
Alabi RO; Elmusrati M; Sawazaki-Calone I; Kowalski LP; Haglund C; Coletta RD; Mäkitie AA; Salo T; Almangush A; Leivo I
Int J Med Inform; 2020 Apr; 136():104068. PubMed ID: 31923822
[TBL] [Abstract][Full Text] [Related]
26. Multi-Source Transfer Learning Via Multi-Kernel Support Vector Machine Plus for B-Mode Ultrasound-Based Computer-Aided Diagnosis of Liver Cancers.
Zhang H; Guo L; Wang D; Wang J; Bao L; Ying S; Xu H; Shi J
IEEE J Biomed Health Inform; 2021 Oct; 25(10):3874-3885. PubMed ID: 33861717
[TBL] [Abstract][Full Text] [Related]
27. Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.
Perfecto-Avalos Y; Garcia-Gonzalez A; Hernandez-Reynoso A; Sánchez-Ante G; Ortiz-Hidalgo C; Scott SP; Fuentes-Aguilar RQ; Diaz-Dominguez R; León-Martínez G; Velasco-Vales V; Cárdenas-Escudero MA; Hernández-Hernández JA; Santos A; Borbolla-Escoboza JR; Villela L
J Transl Med; 2019 Jun; 17(1):198. PubMed ID: 31185999
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma.
Ulu BU; Yiğenoğlu TN; Başcı S; Bakırtaş M; Şahin D; Darçın T; Yaman S; Bozan E; Seçilmiş S; Candır BA; Yıldız J; İskender D; Baysal NA; Çakar MK; Dal MS; Altuntaş F
Leuk Res; 2021 Nov; 110():106700. PubMed ID: 34481125
[TBL] [Abstract][Full Text] [Related]
29. Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary Nodule Recognition Based on Multiple Kernel Learning Support Vector Machine-PSO.
Li Y; Zhu Z; Hou A; Zhao Q; Liu L; Zhang L
Comput Math Methods Med; 2018; 2018():1461470. PubMed ID: 29853983
[TBL] [Abstract][Full Text] [Related]
31. Machine learning-based classification of diffuse large B-cell lymphoma patients by eight gene expression profiles.
Zhao S; Dong X; Shen W; Ye Z; Xiang R
Cancer Med; 2016 May; 5(5):837-52. PubMed ID: 26869285
[TBL] [Abstract][Full Text] [Related]
32. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
Mosquera Orgueira A; Díaz Arias JÁ; Cid López M; Peleteiro Raíndo A; Antelo Rodríguez B; Aliste Santos C; Alonso Vence N; Bendaña López Á; Abuín Blanco A; Bao Pérez L; González Pérez MS; Pérez Encinas MM; Fraga Rodríguez MF; Bello López JL
BMC Cancer; 2020 Oct; 20(1):1017. PubMed ID: 33087075
[TBL] [Abstract][Full Text] [Related]
33. Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
Wang Y; Farooq U; Link BK; Larson MC; King RL; Maurer MJ; Allmer C; Hefazi M; Thompson CA; Micallef IN; Johnston PB; Habermann TM; Witzig TE; Ansell SM; Cerhan JR; Nowakowski GS
J Clin Oncol; 2019 Jul; 37(21):1819-1827. PubMed ID: 31170029
[TBL] [Abstract][Full Text] [Related]
34. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
Larouche JF; Berger F; Chassagne-Clément C; Ffrench M; Callet-Bauchu E; Sebban C; Ghesquières H; Broussais-Guillaumot F; Salles G; Coiffier B
J Clin Oncol; 2010 Apr; 28(12):2094-100. PubMed ID: 20308668
[TBL] [Abstract][Full Text] [Related]
35. Extranodal site of diffuse large B-cell lymphoma and the risk of R-CHOP chemotherapy resistance and early relapse.
Ting CY; Gan GG; Bee-Lan Ong D; Tan SY; Bee PC
Int J Clin Pract; 2020 Oct; 74(10):e13594. PubMed ID: 32583545
[TBL] [Abstract][Full Text] [Related]
36. Multiple-kernel learning for genomic data mining and prediction.
Wilson CM; Li K; Yu X; Kuan PF; Wang X
BMC Bioinformatics; 2019 Aug; 20(1):426. PubMed ID: 31416413
[TBL] [Abstract][Full Text] [Related]
37. Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Porrata LF; Rsitow K; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Habermann TM; Witzig TE; Colgan JP; Nowakowski GS; Thompson CA; Markovic SN
Leukemia; 2010 Jul; 24(7):1343-9. PubMed ID: 20485372
[TBL] [Abstract][Full Text] [Related]
38. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
[TBL] [Abstract][Full Text] [Related]
39. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
40. Discrimination between pathological and normal voices using GMM-SVM approach.
Wang X; Zhang J; Yan Y
J Voice; 2011 Jan; 25(1):38-43. PubMed ID: 20137892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
